Léčba esenciální trombocytémie a dalších myeloproliferativních chorob anagrelidem
|Title in English
|Anagrelid therapy of essential thrombocythemia and other myoproliferative disorders
|Year of publication
|MU Faculty or unit
|The report is a comprehensive analysis of the Czech registry of patients treated with Thromboreductin. The analysis was performed in early 2016 with a cohort of 1,772 patients.